Yasuyuki Yoshida

ZOLL Medical Corp. develops and markets medical devices and related software solutions for emergency care. It provides products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management. The firm provides technologies which help fire professionals, clinicians, and rescuers in providing critical care and resuscitation treatment. It also designs software that automates data documentation and management for both clinical and non-clinical information. The company was founded by William Bright, Rolf S. Stutz, Paul M. Zoll, Leigh Stein, and Thomas M. Claflin in 1980 and is headquartered in Chelmsford, MA.

Asahi Kasei Medical Co. Ltd. engages in the development, manufacture and sale of medical devices. It also engages in the development, manufacture and sale of dialyzers, therapeutic apheresis products, leukocyte reduction filters and virus removal filters. The company was founded on July 24, 1974 and is headquartered in Tokyo, Japan.

Part of Asahi Kasei Corp., Asahi Kasei Pharma Corp. is a pharmaceutical and diagnostic company based in Tokyo, Japan. Asahi Kasei Pharma operates in the healthcare business unit of the Asahi Kasei Group, with a mission to sincerely care for each individual life and solve their unmet medical needs with a wealth of ideas and solid science. Asahi Kasei Corp. is a US $20 billion Japanese technology company that provides innovative, science-based solutions to a diverse range of markets including healthcare, chemicals and fibers, housing and construction materials, and electronics. Founded in 2003, the company has developed innovative drugs in the fields of orthopedics, acute care, neurology (including pain), and immunology.

Asahi Kasei Kuraray Medical is dedicated to the advancement of technology in the fields of hemodialysis, therapeutic apheresis, transfusion therapy, and virus removal for biotherapeutic products. The company works to introduce therapies for intractable diseases by extending the frontiers of medical devices and systems, combining their core technology in functional materials for membrane filtration and selective absorption with pharmacology, chemistry, and mechanical engineering.